Direct lysine dimethylation of IRF3 by the methyltransferase SMYD3 attenuates antiviral innate immunity.

Abstract

Interferon regulatory factor 3 (IRF3) is the key transcription factor in the type I IFN signaling pathway, whose activation is regulated by multiple posttranslational modifications. Here, we identify SMYD3, a lysine methyltransferase, as a negative regulator of IRF3. SMYD3 interacts with IRF3 and catalyzes the dimethylation of IRF3 at lysine 39. This modification reduces IRF3 phosphorylation, dimerization, and subsequent nuclear translocation, leading to the inhibition of downstream type I interferon production. In addition, <i>Smyd3</i>-deficient mice are more resistant to RNA and DNA viral infections. Zebrafish lacking <i>smyd3</i> or treated with the inhibitor BCI121 are also more resistant to viral infection. Our findings reveal a role for <i>SMYD3</i> in the regulation of antiviral innate immunity and provide insight into a specific modulation of IRF3 that affects its activation.